August Ayurveda August Ayurveda August Ayurveda


Vata-types think a lot about sex.

          

          Sunday, October 22, 2017

Search

Home
Our Consultants
Panchakarma Programs
Promotional Support
Document Service
Get Connected
Procure Herbs
Buy Herb Portraits
Order Books
Ayurveda Films
Question and Comments
FREE Online Consultation
Payment Options



$58 Billion Worth
of Heart Diseases

By  AA News Desk

You may be a poet at heart or may be a person too stonehearted, but when hearts behave like estranged spouses, the discord costs billions. The most expensive medical condition in the United States in 1997 was heart disease, which was associated with $58 billion in expenditures, followed by cancer ($46 billion), and trauma-related injuries ($44 billion).

Heart disease accounted for about 10 percent of total expenditures in 1997; cancer and trauma accounted for 8 percent each. However, pulmonary conditions affected the largest number of people (41 million), followed by trauma (37 million), and hypertension (27 million). These are the findings of a study by Joel W. Cohen, Ph.D., and Nancy A. Krauss, M.P.H., of the Center for Cost and Financing Studies, Agency for Healthcare Research and Quality (AHRQ).

In response to an Institute of Medicine request for AHRQ to examine a set of priority conditions, the researchers used 1997 data from the Medical Expenditure Panel Survey (MEPS) to identify the 15 most expensive medical conditions. The MEPS provides estimates of health care use, spending, sources of payment, and insurance coverage for the U.S. civilian non-institutionalized population.

The researchers examined both direct health care costs for the conditions and the total costs for all medical care incurred by people with these conditions. They found that, in general, higher mean expenditures were associated with the extent to which spending was related to inpatient hospitalization. For example, inpatient care accounted for about two-thirds of expenditures for cerebrovascular disease and cancer—the top two conditions in terms of mean expenditures—but only about one-quarter of expenditures were for infectious diseases and skin disorders, the least expensive conditions in the set.

On the other hand, more than half of average spending for kidney disease (which had the third highest mean expenditures) was for outpatient care, most likely related to dialysis. Most people with at least one of the top 15 conditions had other medical problems. Per capita spending increased as much as 8- to 11-fold for people with three or more medical conditions versus only one.

(More details are in "Spending and service use among people with the fifteen most costly medical conditions, 1997," by Dr. Cohen and Ms. Krauss, in the March 2003 Health Affairs 22(2), pp. 129-138.)

These statistics are relatively old, and thus cannot be predictive of what remains the situation now. But, according to another company report, going by the increased sale of heart valves, things seem to have worsened as far as heart diseases are concerned.

Recently a global leader in products and technologies to treat advanced cardiovascular disease, reported heart valve therapy sales of $106.0 million, a 15.7 percent increase compared to the same quarter last year, with foreign exchange (FX) contributing $5.4 million to the growth. Cardiac Surgery Systems sales for the same quarter were $27.0 million.

That, truly, is heartfelt profit..

Archive

Wellness and Wisdom

Homing on the Remedies

Wellness and Wisdom with Sanjay Parva

Lets talk ayurveda

Stress Management
through Ayurveda

6 Tastes and Healing

Archive

Disease management

3 Stages of Awakening

Blue Morphos Butterflies
in the Colombian Jungle:
Success Story with CAM

Archive

Weekly business article

8 Countries to Participate
in 'Raj Ayu Con 2013'

Quest for New Treatments
Drives German Doctor
to Ayurveda

Archive


The world of ayurveda:

the world of ayurveda
the origin of ayurveda
The ayurvedic concept of life


Contact Us | Disclaimer | Privacy Policy       


Copyright (C) 2013 August Ayurveda Pvt. Ltd.
All rights reserved